Cunha Alexandre M, Nascimento Fernanda S, Amaral Jane C O F, Konig Sandra, Takiya Crhistina M, M Neto Vivaldo, Rocha Eduardo, Souza Jorge P B M
Division of Neurosurgery, Department of Surgery, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, RJ, Brazil.
Arq Neuropsiquiatr. 2011 Feb;69(1):112-7. doi: 10.1590/s0004-282x2011000100021.
Several animal experimental models have been used in the study of malignant gliomas. The objective of the study was to test the efficacy of a simple, reproducible and low cost animal model, using human cells of glioblastoma multiforme (GBM) xenotransplantated in subcutaneous tissue of Wistar rats, immunosuppressed with cyclosporin given by orogastric administration, controlled by nonimunosuppressed rats. The animals were sacrificed at weekly intervals and we have observed gradual growth of tumor in the immunosuppressed group. The average tumor volume throughout the experiment was 4.38 cm(3) in the immunosuppressed group, and 0.27 cm(3) in the control one (p<0.001). Tumors showed histopathological hallmarks of GBM and retained its glial identity verified by GFAP and vimentin immunoreaction. Immunosuppression of rats with cyclosporin was efficient in allowing the development of human glioblastoma cells in subcutaneous tissues. The model has demonstrated the maintenance of most of the histopathological characteristics of human glioblastoma in an heterotopic site and might by considered in research of molecular and proliferative pathways of malignant gliomas.
几种动物实验模型已被用于恶性胶质瘤的研究。该研究的目的是测试一种简单、可重复且低成本的动物模型的有效性,该模型使用多形性胶质母细胞瘤(GBM)的人类细胞异种移植到Wistar大鼠的皮下组织中,通过经口胃给药环孢素进行免疫抑制,并由未免疫抑制的大鼠进行对照。动物每周处死一次,我们观察到免疫抑制组肿瘤逐渐生长。整个实验期间,免疫抑制组的平均肿瘤体积为4.38 cm³,对照组为0.27 cm³(p<0.001)。肿瘤显示出GBM的组织病理学特征,并通过GFAP和波形蛋白免疫反应证实保留了其神经胶质特性。用环孢素对大鼠进行免疫抑制有效地使人类胶质母细胞瘤细胞在皮下组织中生长。该模型已证明在异位部位维持了人类胶质母细胞瘤的大多数组织病理学特征,可用于恶性胶质瘤分子和增殖途径的研究。